Vascular reactivity to norepinephrine of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors and normal tissue as studied in vitro
- PMID: 3085919
Vascular reactivity to norepinephrine of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors and normal tissue as studied in vitro
Abstract
Vascular reactivity to norepinephrine has been studied in dimethyl-benz(a)anthracene-induced rat mammary neoplasia and compared with that of skeletal muscle, salivary gland, kidney, and uterus by means of an artificial perfusion technique. Perfusion of tissues and organs was measured with the microsphere tracer technique during smooth muscle relaxation and infusion of norepinephrine at two different dose levels. This procedure makes possible a dose-response analysis of several tissues under controlled conditions without confounding endogenous vasoregulation. The tumor vascular bed has a low perfusion capacity during smooth muscle relaxation and responds rapidly with an increased resistance to norepinephrine infusion. The results indicate a hypersensitivity, although the relative maximal constrictor response is equal to or less than that of other vascular beds studied.
Similar articles
-
Vascular resistance characteristics of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors and normal tissues as studied in vitro.Cancer Res. 1985 Jun;45(6):2478-80. Cancer Res. 1985. PMID: 3921244
-
Vascular reactivity and perfusion characteristics in 7,12-dimethylbenz(a)anthracene-induced rat mammary neoplasia.Cancer Res. 1983 Jan;43(1):363-6. Cancer Res. 1983. PMID: 6401169
-
Acquisition of angiogenic capacity and neoplastic transformation in the rat mammary gland.Cancer Res. 1978 Dec;38(12):4409-14. Cancer Res. 1978. PMID: 102422
-
Effects of oophorectomy on interstitial fluid pressure, blood flow and vascularity in a rat mammary tumour.Anticancer Res. 1997 May-Jun;17(3C):1877-80. Anticancer Res. 1997. PMID: 9216638
-
Perfusion characteristics and norepinephrine reactivity of human renal carcinoma.Cancer Res. 1987 Sep 1;47(17):4709-13. Cancer Res. 1987. PMID: 3621166
Cited by
-
The response of tumour vasculature to angiotensin II revealed by its systemic and local administration to 'tissue-isolated' tumours.Br J Cancer. 1995 Sep;72(3):595-600. doi: 10.1038/bjc.1995.379. Br J Cancer. 1995. PMID: 7669567 Free PMC article.
-
Modification of tumour blood flow using the hypertensive agent, angiotensin II.Br J Cancer. 1993 May;67(5):981-8. doi: 10.1038/bjc.1993.180. Br J Cancer. 1993. PMID: 8494732 Free PMC article.